GEMINI-OS : platform informatics for data-driven neuromodulation

  • Research type

    Research Study

  • Full title

    GEMINI-OS : platform informatics for data-driven neuromodulation

  • IRAS ID

    327169

  • Contact name

    Francesca Morgante

  • Contact email

    fmorgant@sgul.ac.uk

  • Sponsor organisation

    City St George’s, University of London

  • Duration of Study in the UK

    0 years, 11 months, 29 days

  • Research summary

    Deep Brain Stimulation (DBS) is an established treatment for advanced Parkinson's disease (PD). PD is a progressive disease for which there are symptomatic treatments but no cure. In the advanced stages, medications can fail to control symptoms and commonly cause movement and non-movement related side effects. At this stage, people with PD can be referred to a DBS centre where a team of experts, including a neurologist and a brain surgeon, conduct extensive assessments before offering surgery.

    While DBS can be a life-changing treatment, 1 in 4 patients fail to benefit from DBS and some even worsen following surgery. Conversely, some patients who would benefit from it are not offered treatment. Whilst technological improvements in the devices have massively improved the delivery of DBS treatment over the last 20 years, the ability to select the best candidates has remained static. We will recruit patients who are being assessed for their suitability for DBS surgery and patients who have already had their surgery. We will use the data collected as standard of care for these patients, with an optional extra functional MRI, to develop a new clinical tool which will facilitate and improve patient selection for DBS.

    We will develop a novel platform that combines data from before and after surgery to determine what factors predict a good or poor outcome from surgery. Providing a data-driven, objective tool for patient selection, will improve the process by: 1) reducing the number of people who will deteriorate following surgery; 2) increasing the number of people who are offered treatment, including those in the earlier stages; 3) giving clinicians greater confidence in the selection process and potentially allow more patients to benefit.

  • REC name

    East Midlands - Derby Research Ethics Committee

  • REC reference

    25/EM/0053

  • Date of REC Opinion

    17 Feb 2025

  • REC opinion

    Further Information Favourable Opinion